A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients

2007 ◽  
Vol 49 (3) ◽  
pp. 306-312 ◽  
Author(s):  
Evan B. Shereck ◽  
Erin Cooney ◽  
Carmella van de Ven ◽  
Phyllis Della-Lotta ◽  
Mitchell S. Cairo
Sign in / Sign up

Export Citation Format

Share Document